07 January 2010 /Prices and reimbursement
The Danish Medicines Agency initiates the reassessment of reimbursement status of medicines in ATC group N
The Danish Medicines Agency initiates its reassessment of the reimbursement status of medicines in ATC group N (Nervous system). It will take place concurrently with the reassessment process for the remaining subgroups in ATC groups A and J.
04 January 2010 /Side effects and trials
In the period from 12 to 18 December, the Danish Medicines Agency received 48 new side effect reports covering a total of 121 suspected side effects (adverse reactions).